News & Media

Grand Rounds: Update on the Omicron Variant from MDHHS Director Elizabeth Hertel

Grand Rounds: Update on the Omicron Variant from MDHHS Director Elizabeth Hertel

Thursday, January 13, 2022

On Thursday, January 20, from 12:00 – 12:45 pm, Elizabeth Hertel, Director, Michigan Department of Health and Human Services will provide an update on the status of the Omicron variant in Michigan.

Prior to becoming Director of MDHHS, Ms. Hertel was Senior Chief Deputy Director for Administration where she oversaw External Relations and Communications, Financial Operations Administration, Legislative Services, Organizational Services, Workforce Engagement among many other areas.  She joined the Michigan Department of Community Health in 2013 and has held several positions within the department.  

Approved for .75 AMA PRA Category 1 Credit(s)™ 

For more information or to register, click here


Grand Rounds: Omicron – The Next Variant of Concern and Responses in the COVID Pandemic Efforts

On Wednesday, January 26, from 12:00 – 12:45 PM Marty Soehnlen, PhD, MPH, PHLD(ABB) and Heather Blankenship, PhD will provide a presentation on the Omicron variant, how whole genome testing is performed, impacts upon diagnostic tests, current data trends, and impacts upon therapies. 

Doctor Soehnlen is the Director of Infectious Disease at the Michigan Department of Health and Human Services, Bureau of Laboratories.  She began her laboratory career at Ohio State University where she received a BS in Medical Technology followed by an MPH is Hospital and Molecular Epidemiology with a sub-specialization in public health genetics.  Doctor Soehnlen went on to the Centers for Disease Control and Prevention as an APHL/CDC Class XII Emerging Infectious Diseases Fellow in the Rabies group before obtaining a PhD in Pathobiology from Penn State University. 

Doctor Blankenship is the bioinformatics section manager at the Michigan Department of Health and Human Services, Bureau of Laboratories where she provides oversight for genetic analysis. She obtained her bachelors from George Mason University where she specialized in Biotechnology and Molecular Genetics before she pursued her PhD at Michigan State University in Molecular Genetics. While completing her PhD, she joined the Bureau of Laboratories as an NIH fellow to help with the development of the bioinformatics infrastructure and genomic analysis for the state.

Approved for .75 AMA PRA Category 1 Credit(s)™ 

For more information or to register, click here